IPI-504

retaspimycin hydrochloride · Infinity Pharmaceuticals

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for IPI-504, covering 2008-05-20 to 2015-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma [Phase 2]

See pricing